A detailed history of Montag A & Associates Inc transactions in Grifols Sa stock. As of the latest transaction made, Montag A & Associates Inc holds 1,088 shares of GRFS stock, worth $8,508. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,088
Previous 1,088 -0.0%
Holding current value
$8,508
Previous $6,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$6.27 - $7.7 $953 - $1,170
152 Added 16.24%
1,088 $6,000
Q4 2022

Feb 02, 2023

BUY
$5.96 - $8.53 $5,578 - $7,984
936 New
936 $7,000

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.31B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.